Arax Advisory Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Buy
2,234
+1,554
+229% +$333K ﹤0.01% 1677
2026
Q1
$146K Buy
680
+213
+46% +$52.1K ﹤0.01% 1215
2025
Q4
$118K Sell
467
-14,298
-97% -$3.59M ﹤0.01% 1263
2025
Q3
$3.65M Buy
14,765
+13,879
+1,566% +$3.32M 0.05% 307
2025
Q2
$213K Sell
886
-606
-41% -$141K 0.01% 630
2025
Q1
$338K Buy
1,492
+688
+86% +$151K 0.02% 392
2024
Q4
$165K Sell
804
-27
-3% -$5.92K 0.01% 539
2024
Q3
$201K Buy
831
+89
+12% +$20.8K 0.02% 345
2024
Q2
$163K Sell
742
-22
-3% -$4.78K 0.02% 369
2024
Q1
$172K Hold
764
0.02% 312
2023
Q4
$168K Buy
764
+325
+74% +$68.7K 0.02% 307
2023
Q3
$96.4K Buy
439
+24
+6% +$5.43K 0.01% 353
2023
Q2
$93.4K Sell
415
-16
-4% -$3.2K 0.01% 357
2023
Q1
$82.4K Buy
431
+24
+6% +$4.64K 0.01% 380
2022
Q4
$75.1K Sell
407
-21
-5% -$3.69K 0.01% 381
2022
Q3
$71K Buy
428
+12
+3% +$2.44K 0.01% 372
2022
Q2
$86K Sell
416
-1
-0.2% -$225 0.01% 332
2022
Q1
$101K Sell
417
-3
-0.7% -$695 0.01% 338
2021
Q4
$102K Sell
420
-31
-7% -$7.08K 0.01% 341
2021
Q3
$92K Buy
451
+1
+0.2% +$214 0.01% 351
2021
Q2
$93K Buy
+450
New +$90.6K 0.01% 350
2020
Q4
$73K Buy
385
+14
+4% +$2.61K 0.01% 345
2020
Q3
$65K Buy
371
+24
+7% +$3.84K 0.01% 334
2020
Q2
$53K Sell
347
-5
-1% -$762 0.01% 357
2020
Q1
$49K Sell
352
-23
-6% -$3.44K 0.01% 350
2019
Q4
$57K Sell
375
-26
-6% -$3.81K 0.02% 324
2019
Q3
$58K Hold
401
0.02% 316
2019
Q2
$60K Buy
+401
New +$53.6K 0.02% 299
2018
Q4
$45K Sell
425
-17
-4% -$1.9K 0.02% 283
2018
Q3
$51K Buy
+442
New +$50K 0.02% 287

Other funds holding STE

Arax Advisory Partners's STE Position: Q2 2026 in Review

Arax Advisory Partners increased its Steris (STE) stake by 229% in Q2 2026, buying an estimated $333K and bringing the position to 2,234 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

Arax Advisory Partners first reported a position in STE in Q3 2018 and has held it in 30 quarters since. The position peaked at $3.65M in Q3 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Arax Advisory Partners held 2,234 shares of Steris worth $470K as of Q2 2026.
  • Arax Advisory Partners bought 1,554 Steris shares in Q2 2026, an estimated $333K.
  • Steris made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1677 holding.
  • Arax Advisory Partners first reported a position in Steris in Q3 2018 and has held it in 30 quarters since.
  • Arax Advisory Partners's Steris position peaked at $3.65M in Q3 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.